Selective cyclooxygenase 2 inhibitors and cardiovascular events


  • Daniel H. Solomon

    Corresponding author
    1. Brigham and Women's Hospital, Boston, Massachusetts
    • Division of Pharmacoepidemiology, Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston MA 02120
    Search for more papers by this author